Dr Shashank Sharma

Qualifications

MRCP (Respiratory), FRCP (Medicine), PG Certificate in Medical Education

GMC number: 6072505

Practising since: 2001

Specialties

Respiratory Medicine

Consultation times

  • Friday afternoons
  • Overview
Enquire now

About

Dr Shashank Sharma is a Consultant in Respiratory Medicine, specialising in asthma, COPD, pulmonary fibrosis, lung cancer, sleep apnoea and recurrent chest infections.

Dr Shashank joined Ashford and St Peter’s Hospital (ASPH) in 2014 as a Respiratory consultant, where he successfully introduced multiple new services including an Ambulatory Pleural Service and Medical Thoracoscopy, both of which are highly regarded.

He has also set up a collaborative multi-disciplinary team (MDT) meeting with his respiratory colleagues at Royal Brompton Hospital, to improve the care of patients with pulmonary fibrosis at ASPH.

As the lead for Respiratory Medicine at ASPH, he led the departmental response to the Covid-19 pandemic and has developed expertise in acute as well as Chronic/Long Covid.

He was involved in the development of a novel ambulatory management pathway for Covid patients, which was commended by NHSE and subsequently adopted across Surrey’s primary care services during the second and thrid waves of the pandemic.

Dr Sharma is the Clinical lead for Respiratory in NHS Surrey Heartlands. He works closely with all the acute trusts as well as primary care in Surrey to develop Respiratory services in line with national NHS priorities. One of the ongoing projects is to implement Targeted Lung Health Checks throughout SurreyHeartlands for early diagnosis of Lung cancer

Special interests

• Chronic Intractable Cough
• Sleep apnoea
• Breathlessness
• Asthma
• COPD
• Bronchiectasis
• Pulmonary Fibrosis
• Lung cancer
• Bronchoscopy
• EBUS and Medical Thoracoscopy
• TB
• Long Covid
• Pneumonia and recurrent chest infections

• Pleural effusion

Personal interests

Yoga
Sports
Tennis
Badminton
Karate
Walking 

Listening to podcasts

Languages spoken

English, Hindi

Locations Dr Shashank Sharma works with

Related experience

Research

- Leflunomide treatment for patients hospitalised with COVID-19: DEFEAT-COVID randomised controlled trial’. BMJ Open 2023;13:e068179. doi:10.1136/bmjopen-2022-068179 Ines Kralj-Hans, Kuo Li, Adrian Wesek, Alexia Lamorgese, Fatima Omar, Kapila Ranasinghe, Megan McGee, Kieran Brack, Shiliang Li, Ritesh Aggarwal, Ajay Bulle, Aparna Kodre, Shashank Sharma, David Fluck, Isaac John, Pankaj Sharma, Jonathan D Belsey, Ling Li, Sreenivasa Rao Kondapally Seshasai, Hong Lin Li, Nandor Marczin, Zhong Chen

- Chest radiographs may assist in predicting the outcome in the early phase of Covid-19. UK district general hospital experience of Covid-19 first wave’. Expert Review of Respiratory Medicine Volume 15, 2021 - Issue 4 Max Berrill,Jola Karaj,Georgiana Zamfir,Jordan Colman,Rachel Mason,Saeed Akbar,Shashank Sharma,Frances Sheehan,Kanchan Dhamija,Felicity Saltissi,Aigul Baltabaeva &Sujoy Saikia

- ‘A novel ambulatory management pathway for Cobid-19 patients using home oximetry’. European Respiratory Journal 2021 58: PA3673; DOI: 10.1183/13993003.congress-2021.PA3673 Shashank Sharma, Sujoy Saikia, Ali Fawzi, Sriram Thillainayagam, C Wade, Frederick Tibbs, Elise Spiers, Jola Karaj

- ‘The role of CT Thorax scans in triaging suspected cases of Covid-19’. European Respiratory Journal 2021 58: PA3246; DOI: 10.1183/13993003.congress-2021.PA3246 Mary Flynn, Hyun Park, K Aguilaresguerra, A Fawzi, S Saikia, A Chapman, S Sharma

- ‘Pembrolizumab-induced subacute sensory ataxia’. VOLUME 115, SUPPLEMENT 1, S8-S9, JANUARY 2018. DOI:https://doi.org/10.1016/S0169-5002(18)30045-X A.J.S. Furness, J. Coebergh, M. Wood, M. Irvine-Sellars, S. Saikia, S. Sharma, B. McBride, C. Johnson, M. Teoh, F. Cockroft, S. Wing, P. Murray, M. Hewish

- Oxygen desaturation index for diagnosing obstructive sleep apnoea in patients with morbid obesity December 2017, Thorax 72(Suppl 3):A115-A115, DOI: 10.1136/thoraxjnl-2017-210983.204 A Fawzi, Hussain Helal Basheer, M Patel, S Sharma

- ‘Stroke due to thromboembolism from congenital aneurysm of ventricular septum’. Acute Med. 2008; 7(1): 43-4. S.Sharma, A Thomas, A. Baghomian, N. Waterfield. Published in Acute Medicine (Volume 7 Issue 1, 2008).

- A comparative evaluation of the efficacy of inhaled Beclomethasone dipropionate, Budesonide and Fluticasone propionate in the management of Bronchial Asthma’. U Parikh, K.Gupta,

Memberships

  • Royal College of Physicians
  • Medical Protection Society
  • GMC

Other posts held

  • Ashford and St. Peter’s Hospitals NHS Foundation Trust - Respiratory Consultant
  • NHS Surrey Heartlands ICB – Respiratory Lead

Insurers Dr Shashank Sharma works with

Dr Shashank Sharma works with the following private medical insurance providers:

  • Aviva Health
  • AXA - Global Healthcare
  • AXA Health
  • Benenden Health
  • Bupa
  • Cigna
  • InterGlobal
  • Medical Care Direct
  • PHC
  • Universal Provident
  • Vitality Health (Pru Health)
  • Westfield Health WPA

Declaration

Dr Shashank Sharma does not hold a share or financial interest in this hospital, another Nuffield Health hospital or the company.

Dr Shashank Sharma does not have a share or financial interest in equipment used at this hospital or another Nuffield Health hospital.

Dr Shashank Sharma does not hold any paid advisory role(s) at this hospital or on behalf of Nuffield Health.